Pharma & Biotech

Entrada Therapeutics, once a promising biotech contender, now finds itself navigating turbulent market conditions. Current shareholders are facing substantial erosion...

Capricor Therapeutics finds itself at a critical juncture, with its shares embodying a stark contrast between ambitious analyst projections and...

The future of clinical-stage pharmaceutical company HilleVax will be determined on Monday as the takeover bid from biotechnology specialist XOMA...

Soleno Therapeutics finds itself navigating turbulent waters after reports emerged of a patient fatality connected to its lead drug candidate,...

Indian pharmaceutical giant Dr. Reddy's Laboratories finds itself balancing on a strategic tightrope. The company is simultaneously addressing significant regulatory...

Despite boasting a promising development pipeline and solid financial metrics, Arcus Biosciences shares are confronting significant valuation challenges. The biopharmaceutical...

The investment landscape surrounding healthcare distributor McKesson presents a fascinating divergence of opinion. While major institutional players are building significant...

A puzzling divergence is capturing investor attention in the biotech sector. Biomarin Pharmaceutical Inc., a company delivering groundbreaking therapies and...

The Cooper Companies' latest quarterly earnings have placed its shares under the microscope. While the medical device manufacturer demonstrated solid...

Despite announcing a series of significant clinical breakthroughs and maintaining a robust financial position, BioNTech SE shares experienced notable downward...